Vertex Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CAPITAL WORLD INVESTORS | 02/11/2026 | 25.51 M | $11.57 B | -1.55% | 9.98% |
| VANGUARD GROUP INC | 01/29/2026 | 24.11 M | $10,928.62 B | -0.46% | 9.49% |
| BLACKROCK, INC. | 02/12/2026 | 23.75 M | $10.77 B | 6.74% | 9.35% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 02/11/2026 | 17.32 M | $7.85 B | 4.61% | 6.77% |
| STATE STREET CORP | 02/13/2026 | 11.69 M | $5.30 B | 0.72% | 4.60% |
| JPMORGAN CHASE & CO | 02/11/2026 | 6.04 M | $2.74 B | -6.14% | 2.36% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 5.98 M | $2,700.21 B | 0.14% | 2.36% |
| CAPITAL INTERNATIONAL INVESTORS | 02/11/2026 | 4.73 M | $2.15 B | 0.95% | 1.85% |
| LOOMIS SAYLES & CO L P | 02/12/2026 | 4.03 M | $1.83 B | -2.15% | 1.58% |
| VICTORY CAPITAL MANAGEMENT INC | 02/13/2026 | 3.36 M | $1.52 B | 49.35% | 1.31% |
| JENNISON ASSOCIATES LLC | 01/30/2026 | 3.25 M | $1.47 B | -5.95% | 1.27% |
| NORGES BANK | 02/10/2026 | 3.18 M | $1.44 B | 100.00% | 1.24% |
| MORGAN STANLEY | 02/13/2026 | 3.12 M | $1.41 B | 0.38% | 1.23% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/13/2026 | 3.00 M | $1.36 B | 3.94% | 1.17% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 2.94 M | $1,331.53 B | 3.40% | 1.16% |
| CLEARBRIDGE INVESTMENTS, LLC | 02/11/2026 | 2.86 M | $1.30 B | 8.10% | 1.12% |
| LEGAL & GENERAL GROUP PLC | 02/09/2026 | 1.97 M | $893.17 M | 0.91% | 0.77% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 1.86 M | $842.90 M | 1.60% | 0.73% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 1.77 M | $801.94 M | 10.52% | 0.69% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 1.75 M | $794.92 B | 18.10% | 0.69% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 1.53 M | $692.55 M | -2.65% | 0.60% |
| ROYAL BANK OF CANADA | 02/17/2026 | 1.19 M | $541.54 M | 0.07% | 0.47% |
| WCM INVESTMENT MANAGEMENT, LLC | 02/09/2026 | 1.13 M | $512.34 M | -1.82% | 0.44% |
| EDGEWOOD MANAGEMENT LLC | 02/12/2026 | 1.06 M | $480.60 M | -28.74% | 0.41% |
| NUVEEN, LLC | 02/12/2026 | 1.04 M | $472.58 M | -3.28% | 0.41% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 945.66 K | $428.73 M | 20.68% | 0.37% |
| WINSLOW CAPITAL MANAGEMENT, LLC | 02/12/2026 | 887.64 K | $405.10 M | 100.00% | 0.35% |
| BARCLAYS PLC | 02/13/2026 | 847.76 K | $384.34 M | 14.18% | 0.33% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 848.64 K | $384.74 M | 88.93% | 0.33% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/09/2026 | 832.85 K | $377.58 M | 9.05% | 0.33% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 752.43 K | $342.20 M | -4.93% | 0.29% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 741.81 K | $336.31 M | 3.41% | 0.29% |
| SWISS NATIONAL BANK | 02/12/2026 | 702.60 K | $318.53 M | -5.09% | 0.27% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 02/13/2026 | 669.81 K | $303.72 M | 46.78% | 0.26% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 01/23/2026 | 654.47 K | $296.71 M | -6.59% | 0.26% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/13/2026 | 593.95 K | $269.27 M | 55.81% | 0.23% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 589.10 K | $267.07 M | -1.29% | 0.23% |
| MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 02/03/2026 | 566.23 K | $256.01 M | 3.90% | 0.22% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 559.54 K | $253.67 M | 120.00% | 0.22% |
| VOYA INVESTMENT MANAGEMENT LLC | 02/12/2026 | 562.35 K | $254.37 M | 30.10% | 0.22% |
| UBS GROUP AG | 01/29/2026 | 555.98 K | $252.06 M | -28.08% | 0.22% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/13/2026 | 557.71 K | $252.88 M | 9.32% | 0.22% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 02/12/2026 | 556.06 K | $252.10 M | -9.22% | 0.22% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 550.60 K | $249.62 M | 18.93% | 0.22% |
| NEUBERGER BERMAN GROUP LLC | 02/13/2026 | 545.90 K | $247.49 M | 3.49% | 0.21% |
| CITIGROUP INC | 02/13/2026 | 539.93 K | $244.78 M | -0.01% | 0.21% |
| NATIONAL PENSION SERVICE | 02/10/2026 | 530.84 K | $240.66 M | 3.66% | 0.21% |
| NATIXIS ADVISORS, L.P. | 02/10/2026 | 527.86 K | $239.31 M | -1.74% | 0.21% |
| B. METZLER SEEL. SOHN & CO. AG | 01/28/2026 | 515.27 K | $233.58 M | 63.36% | 0.20% |
| DEKABANK DEUTSCHE GIROZENTRALE | 01/28/2026 | 506.46 K | $219.78 M | 0.00% | 0.20% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Vertex Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 2022 institutional investors and hedge funds held shares of Vertex Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Capital World Investors: 25.51 M
VANGUARD GROUP INC: 24.11 M
BlackRock, Inc.: 23.75 M
Capital Research Global Investors: 17.32 M
STATE STREET CORP: 11.69 M
JPMORGAN CHASE & CO: 6.04 M
90.94% of Vertex Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 271.63 M shares in the last 24 months. This purchase volume represents approximately $127.47 B in transactions.